次季亞太區5G手機出貨量Vivo居首位
調查機構Strategy Analytics發表的報告指,今年第二季Vivo 5G出貨量市佔爲亞太區第一達20%,該行指出Vivo是亞太區領先智能手機品牌,年度出貨量增長達215%,認爲公司捕捉了華爲跌勢帶來的機遇,加上旗下手機價格可負擔,成爲亞太區最受歡迎5G設備。
而小米(01810.HK)5G手機出貨量則爲亞太區第二,次季按年增長286%,主要受惠中國推動增長,Oppo、蘋果(AAPL.US)及三星分別排第三至五位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.